{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:38:52Z","timestamp":1761809932500,"version":"build-2065373602"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Visceral Surgery"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jviscsurg.2023.07.008","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T12:21:51Z","timestamp":1694866911000},"page":"444-455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["What should a surgeon know about hidradenitis suppurativa?"],"prefix":"10.1016","volume":"160","author":[{"given":"Anne Cecile","family":"Ezanno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Guillem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Gorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germaine","family":"Gabison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brice","family":"Malgras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Claire","family":"Fougerousse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jviscsurg.2023.07.008_bib0305","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat","year":"2020","journal-title":"Nat Rev Dis Primer"},{"issue":"5","key":"10.1016\/j.jviscsurg.2023.07.008_bib0310","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.annder.2018.01.043","article-title":"Misdiagnosis of hidradenitis suppurativa continues to be a major issue. The R-ENS Verneuil study","volume":"145","author":"Loget","year":"2018","journal-title":"Ann Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jviscsurg.2023.07.008_bib0315","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/bjd.17537","article-title":"British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa)","volume":"180","author":"Ingram","year":"2019","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jviscsurg.2023.07.008_bib0320","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","article-title":"Clinical practice. Hidradenitis suppurativa","volume":"366","author":"Jemec","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jviscsurg.2023.07.008_bib0325","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaad.2020.08.045","article-title":"Hidradenitis suppurativa in pediatric patients","volume":"86","author":"Choi","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jviscsurg.2023.07.008_bib0330","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jviscsurg.2023.07.008_bib0335","first-page":"62","article-title":"Hidradenitis suppurativa is an autoinflammatory keratinization disease: a review of the clinical, histologic, and molecular evidence","volume":"1","author":"Frew","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"5 Suppl. 1","key":"10.1016\/j.jviscsurg.2023.07.008_bib0340","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.jaad.2015.07.045","article-title":"Pathophysiology of hidradenitis suppurativa: an update","volume":"73","author":"Prens","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jviscsurg.2023.07.008_bib0345","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/exd.12098","article-title":"Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology","volume":"22","author":"Melnik","year":"2013","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1016\/j.jviscsurg.2023.07.008_bib0350","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2340\/00015555-1492","article-title":"Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa","volume":"93","author":"Mozeika","year":"2013","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.jviscsurg.2023.07.008_bib0355","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/bjd.15007","article-title":"Bacterial biofilm in chronic lesions of hidradenitis suppurativa","volume":"176","author":"Ring","year":"2017","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jviscsurg.2023.07.008_bib0360","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jaci.2020.01.045","article-title":"Anti-Saccharomyces cerevisiae IgG and IgA antibodies are associated with systemic inflammation and advanced disease in hidradenitis suppurativa","volume":"146","author":"Assan","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jviscsurg.2023.07.008_bib0365","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/bjd.13864","article-title":"Overweight, diabetes and disease duration influence clinical severity in hidradenitis suppurativa-acne inversa: evidence from the national Italian registry","volume":"174","author":"Bettoli","year":"2016","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jviscsurg.2023.07.008_bib0370","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/bjd.15904","article-title":"Adipokines are dysregulated in patients with hidradenitis suppurativa","volume":"178","author":"Malara","year":"2018","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jviscsurg.2023.07.008_bib0375","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jviscsurg.2023.07.008_bib0380","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.det.2015.08.004","article-title":"Inflammatory mechanisms in hidradenitis suppurativa","volume":"34","author":"Kelly","year":"2016","journal-title":"Dermatol Clin"},{"issue":"4","key":"10.1016\/j.jviscsurg.2023.07.008_bib0385","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamadermatol.2015.6264","article-title":"Risk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa","volume":"152","author":"Egeberg","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"11","key":"10.1016\/j.jviscsurg.2023.07.008_bib0390","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1111\/jdv.15764","article-title":"High prevalence of non-alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors","volume":"33","author":"Dur\u00e1n-Vian","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jviscsurg.2023.07.008_bib0395","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.det.2015.08.002","article-title":"Prevalence, risk factors, and comorbidities of hidradenitis suppurativa","volume":"34","author":"Miller","year":"2016","journal-title":"Dermatol Clin"},{"issue":"6","key":"10.1016\/j.jviscsurg.2023.07.008_bib0400","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/bjd.13122","article-title":"Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities","volume":"171","author":"Crowley","year":"2014","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jviscsurg.2023.07.008_bib0405","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jaad.2018.09.040","article-title":"Overall and subgroup prevalence of acne vulgaris among patients with hidradenitis suppurativa","volume":"80","author":"Wertenteil","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jviscsurg.2023.07.008_bib0410","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jamadermatol.2018.0878","article-title":"Overall and subgroup prevalence of Crohn disease among patients with hidradenitis suppurativa: a population-based analysis in the United States","volume":"154","author":"Garg","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jviscsurg.2023.07.008_bib0415","doi-asserted-by":"crossref","first-page":"676241","DOI":"10.3389\/fmed.2021.676241","article-title":"Features associated with quality of life impairment in hidradenitis suppurativa patients","volume":"8","author":"Schneider-Burrus","year":"2021","journal-title":"Front Med"},{"issue":"3","key":"10.1016\/j.jviscsurg.2023.07.008_bib0420","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1001\/jamadermatol.2019.4590","article-title":"Risk of inflammatory arthritis after a new diagnosis of hidradenitis suppurativa","volume":"156","author":"Schneeweiss","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jviscsurg.2023.07.008_bib0425","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1159\/000448838","article-title":"High Prevalence of back pain and axial spondyloarthropathy in patients with hidradenitis suppurativa","volume":"232","author":"Schneider-Burrus","year":"2016","journal-title":"Dermatology (Basel)"},{"issue":"5","key":"10.1016\/j.jviscsurg.2023.07.008_bib0430","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jid.2016.11.040","article-title":"Prevalence and risk of inflammatory bowel disease in patients with hidradenitis suppurativa","volume":"137","author":"Egeberg","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jviscsurg.2023.07.008_bib0435","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/bjd.20954","article-title":"New insights in hidradenitis suppurativa from a population-based Dutch cohort: prevalence, smoking behaviour, socioeconomic status and comorbidities","volume":"186","author":"Prens","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jviscsurg.2023.07.008_bib0440","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3389\/fimmu.2018.02965","article-title":"Hidradenitis suppurativa: a systematic review integrating inflammatory pathways into a cohesive pathogenic model","volume":"9","author":"Vossen","year":"2018","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.jviscsurg.2023.07.008_bib0445","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/jdv.14464","article-title":"Recognizing syndromic hidradenitis suppurativa: a review of the literature","volume":"31","author":"Gasparic","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.jviscsurg.2023.07.008_bib0450","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jid.2018.01.009","article-title":"Hidradenitis suppurativa is associated with polycystic ovary syndrome: a population-based analysis in the United States","volume":"138","author":"Garg","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"10","key":"10.1016\/j.jviscsurg.2023.07.008_bib0455","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2340\/00015555-3225","article-title":"Dowling-Degos disease and hidradenitis suppurativa. epidemiological and clinical study of 15 patients and review of the literature","volume":"99","author":"Agut-Busquet","year":"2019","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"10.1016\/j.jviscsurg.2023.07.008_bib0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ASW.0000753196.64470.6a","article-title":"Should we scan hidradenitis suppurativa patients? A systematic review of radiologic findings","volume":"34","author":"Gutfilen-Schlesinger","year":"2021","journal-title":"Adv Skin Wound Care"},{"issue":"9","key":"10.1016\/j.jviscsurg.2023.07.008_bib0465","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1111\/jdv.15629","article-title":"Characterization of perianal fistulas in patients with hidradenitis suppurativa","volume":"33","author":"Scholtes","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5 Suppl. 1","key":"10.1016\/j.jviscsurg.2023.07.008_bib0470","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jaad.2015.07.047","article-title":"New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes","volume":"73","author":"Van der Zee","year":"2015","journal-title":"J Am Acad Dermatol"},{"year":"1989","series-title":"Dermatological surgery: principles and practice","author":"Hurley","key":"10.1016\/j.jviscsurg.2023.07.008_bib0475"},{"issue":"2","key":"10.1016\/j.jviscsurg.2023.07.008_bib0480","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0151-9638(07)91613-0","article-title":"Modifications to the Sartorius score and instructions for evaluating the severity of suppurative hidradenitis","volume":"134","author":"Revuz","year":"2007","journal-title":"Ann Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jviscsurg.2023.07.008_bib0485","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/bjd.15748","article-title":"Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity","volume":"177","author":"Zouboulis","year":"2017","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jviscsurg.2023.07.008_bib0490","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/jdv.13216","article-title":"HiSCR (hidradenitis suppurativa clinical response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study","volume":"30","author":"Kimball","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jviscsurg.2023.07.008_bib0495","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jaad.2020.03.041","article-title":"The prevalence and odds of anxiety and depression in children and adults with hidradenitis suppurativa: systematic review and meta-analysis","volume":"83","author":"Jalenques","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jviscsurg.2023.07.008_bib0500","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jaad.2018.02.053","article-title":"Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: a population-based analysis in the United States","volume":"79","author":"Garg","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jviscsurg.2023.07.008_bib0505","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","article-title":"Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis","volume":"71","author":"Shlyankevich","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jviscsurg.2023.07.008_bib0510","first-page":"730","article-title":"Incidence of cancer among patients with hidradenitis suppurativa","volume":"137","author":"Lapins","year":"2001","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jviscsurg.2023.07.008_bib0515","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/bjd.19710","article-title":"Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology","volume":"184","author":"Bertolotti","year":"2021","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jviscsurg.2023.07.008_bib0520","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","article-title":"Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa","volume":"39","author":"Jemec","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"10378","key":"10.1016\/j.jviscsurg.2023.07.008_bib0525","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(23)00022-3","article-title":"Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials","volume":"401","author":"Kimball","year":"2023","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jviscsurg.2023.07.008_bib0530","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/jamadermatol.2021.2905","article-title":"Efficacy and safety of bimekizumab in moderate to severe hidradenitis suppurativa: a phase 2, double-blind, placebo-controlled randomized clinical trial","volume":"157","author":"Glatt","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"9","key":"10.1016\/j.jviscsurg.2023.07.008_bib0535","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/jdv.14892","article-title":"Surgical treatment of hidradenitis suppurativa: an analysis of postoperative outcome, cosmetic results and quality of life in 255 patients","volume":"32","author":"Kofler","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.jviscsurg.2023.07.008_bib0540","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1468-3083.2011.04203.x","article-title":"Mild to moderate hidradenitis suppurativa treated with local excision and primary closure","volume":"26","author":"Van Rappard","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5 Suppl. 1","key":"10.1016\/j.jviscsurg.2023.07.008_bib0545","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.jaad.2015.07.044","article-title":"Recurrence of hidradenitis suppurativa after surgical management: a systematic review and meta-analysis","volume":"73","author":"Mehdizadeh","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jviscsurg.2023.07.008_bib0550","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000507323","article-title":"Medical and surgical management of hidradenitis suppurativa: a review of international treatment guidelines and implementation in general dermatology practice","volume":"236","author":"Orenstein","year":"2020","journal-title":"Dermatology (Basel)"},{"issue":"1","key":"10.1016\/j.jviscsurg.2023.07.008_bib0555","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaad.2016.08.031","article-title":"Inflammatory bowel disease is associated with hidradenitis suppurativa: results from a multicenter cross-sectional study","volume":"76","author":"Deckers","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jviscsurg.2023.07.008_bib0560","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaad.2017.01.055","article-title":"The role of wide local excision for the treatment of severe hidradenitis suppurativa (Hurley grade III): retrospective analysis of 74 patients","volume":"77","author":"Posch","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jviscsurg.2023.07.008_bib0565","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jdv.14770","article-title":"Hidradenitis suppurativa treated with wide excision and second intention healing: a meaningful local cure rate after 253 procedures","volume":"32","author":"Deckers","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jviscsurg.2023.07.008_bib0570","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1524-4725.2011.02255.x","article-title":"Surgical treatment of sinuses by deroofing in hidradenitis suppurativa","volume":"38","author":"Van Hattem","year":"2012","journal-title":"Dermatol Surg"},{"issue":"19","key":"10.1016\/j.jviscsurg.2023.07.008_bib0575","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.3390\/jcm11195813","article-title":"Outcomes and reliability of perforator flaps in the reconstruction of hidradenitis suppurativa defects: a systemic review and meta-analysis","volume":"11","author":"Vaillant","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.jviscsurg.2023.07.008_bib0580","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/iwj.13678","article-title":"The role of negative-pressure wound therapy in the management of axillary hidradenitis suppurativa","volume":"19","author":"Ezanno","year":"2022","journal-title":"Int Wound J"},{"issue":"6570","key":"10.1016\/j.jviscsurg.2023.07.008_bib0585","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/bmj.294.6570.487","article-title":"Recurrence after surgical treatment of hidradenitis suppurativa","volume":"294","author":"Harrison","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"4","key":"10.1016\/j.jviscsurg.2023.07.008_bib0590","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1097\/DSS.0000000000002815","article-title":"Recurrence rates following reconstruction strategies after wide excision of hidradenitis suppurativa: a systematic review and meta-analysis","volume":"47","author":"Ovadja","year":"2021","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.jviscsurg.2023.07.008_bib0595","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.anplas.2018.06.013","article-title":"Radical treatment of hidradenitis suppurativa: Comparison of the use of the artificial dermis and pedicled perforator flaps","volume":"64","author":"Gibrila","year":"2019","journal-title":"Ann Chir Plast Esthet"},{"issue":"11","key":"10.1016\/j.jviscsurg.2023.07.008_bib0600","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jamasurg.2021.3655","article-title":"Efficacy and safety of adalimumab in conjunction with surgery in moderate to severe hidradenitis suppurativa: the SHARPS randomized clinical trial","volume":"156","author":"Bechara","year":"2021","journal-title":"JAMA Surg"}],"container-title":["Journal of Visceral Surgery"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187878862300142X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187878862300142X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:34:01Z","timestamp":1761809641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187878862300142X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S187878862300142X"],"URL":"https:\/\/doi.org\/10.1016\/j.jviscsurg.2023.07.008","relation":{},"ISSN":["1878-7886"],"issn-type":[{"type":"print","value":"1878-7886"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What should a surgeon know about hidradenitis suppurativa?","name":"articletitle","label":"Article Title"},{"value":"Journal of Visceral Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviscsurg.2023.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}